| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.003 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.007 | 1 |